Volume Replacement Therapy during Hip Arthroplasty using Hydroxyethyl Starch (130/0.4) Compared to Lactated Ringer Decreases Allogeneic Blood Transfusion and Postoperative Infection

Revista Brasileira de Anestesiologia

Volumn 63, Issue 1, 2013, Pages 27-44

  Hamaji, Adilson ^a   Hajjar, Ludhmila ^a   Caiero, Marcelo ^a   Almeida, Juliano ^a   Nakamura, Rosana Ely ^a   Osawa, Eduardo A ^a   Fukushima, Julia ^a   Galas, Filomena R ^a   Auler Junior, Jose Otavio Costa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anesthesia; Arthroplasty; Blood Transfusion; Hemodilution; Hetastarch; Hip; Replacement; Spinal

Indexed keywords

BUPIVACAINE; HEMOGLOBIN; HETASTARCH; PROPOFOL; RINGER LACTATE SOLUTION; HETASTARCH DERIVATIVE; ISOTONIC SOLUTION; PLASMA SUBSTITUTE; RINGER'S LACTATE;

ADULT; ARTICLE; BIOCHEMISTRY; BLEEDING; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HEMODYNAMIC PARAMETERS; HIP ARTHROPLASTY; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; MALE; MORTALITY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SPINAL ANESTHESIA; SUBSTITUTION THERAPY; THROMBOCYTE AGGREGATION; BLOOD TRANSFUSION; BLOOD VOLUME; COMPARATIVE STUDY; CROSS INFECTION; DRUG EFFECTS; HEMODYNAMICS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ARTHROPLASTY, REPLACEMENT, HIP; BLOOD TRANSFUSION; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMICS; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; INTRAOPERATIVE CARE; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; BLOOD VOLUME; CROSS INFECTION; POSTOPERATIVE COMPLICATIONS;

EID: 84927170588     PISSN: 00347094     EISSN: 1806907X     Source Type: Journal    
DOI: 10.1016/S0034-7094(13)70196-X     Document Type: Article

References (74)

1. Jones S.B., Whitten C.W., Despotis G.J., Monk T.G. The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers. Anesth Analg 2003, 96:363-368.
2. Lang K., Boldt J., Suttner S., Haisch G. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg 2001, 93:405-409.
3. Boldt J., Lehmann A., Römpert R., Haisch G., Isgro F. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2000, 14:264-268.
4. Karanko M.S., Klossner J.A., Laaksonen V.O. Restoring volume by crystalloid versus colloid after coronary artery bypass: hemodynamics, lung water, oxygenation, and outcome. Crit Care Med 1987, 15:559-566.
5. Boldt J., Knothe C., Zickmann B., et al. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg 1993, 76:1185-1190.
6. Haisch G., Boldt J., Krebs C., et al. Influence of a new hydroxyethyl starch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth 2001, 15:316-321.
7. Gallandat R.C.G., Siemons A.W., Baus D., et al. A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anesth 2000, 47:1207-1215.
8. Grauer M.T., Baus D., Woessner R., et al. Effects on general safety and coagulation after long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study. Critical Care 2001, 5:S115-S154.
9. Langeron O., Doelberg M., Ang E.T., Bonnet F., Capdevila X., Coriat P Voluven® a lower substituted novel hydroxyethylstarch (HES 130/0.4) causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001, 92:855-862.
10. Gandhi S.D., Weiskopf R.B., Jungheinrich C., et al. Volume replacement therapy during major orthopedic surgery using Voluven® (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiol 2007, 106:1120-1127.
11. Hébert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340:409-417.
12. Taylor R.W., O'Brien J.R.N., Trottier Steven J., et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Crit Care Med 2006, 34:2302-2308.
13. Hladik W., Dollard Sheila, Mermin J., et al. Transmission of Human Herpesvirus 8 by Blood Transfusion. New Engl J Med 2006, 355:1331-1338.
14. Innerhofer P., Walleczek C., Luz G., et al. Transfusion of buffy coatdepleted blood components and risk of postoperative infection in orthopedic patients. Transfusion 1999, 39:625-632.
15. Spiess B.D. Red cell transfusions and Guidelines: a work in progress. Hematol Oncol Clin North Am 2007, 21:185-200.
16. D'Ambrosio A., Borghi B., Damato A., D'Amato G., Antonacci D., Valeri F. Reducing perioperative blood loss in patients undergoing total hip arthroplasty. Int J Artif Organs 1999, 22:47-51.
17. Lentschener C., Cottin P., Bouaziz H., et al. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion. Anesth Analg 1999, 89:590-597.
18. Finfer S., Bellomo R., Boyce N., French J., Myburgh J., Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2256.
19. Cardinal D.C., Flower RJ The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980, 3:135-158.
20. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. AmJ Respir Crit Care Med 1994, 149:818-824.
21. Thygesen K., Alpert J.S., White H.D. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction - Universal definition of myocardial infarction. J Am Coll Cardiol 2007, 50:2173-2195.
22. Haase M., Bellomo R., Matalanis G., Calzavacca P., Dragun D., Haase- Fielitz A A comparison of the RIFLE and Acute Kidney Injury Network classifications for cardiac surgery - associated acute kidney injury. J Thorac Cardiovasc Surg 2009, 138:1370-1376.
23. Despotis G.J., Skubas N.J., Goodnough LT Optimal management of bleeding and transfusion in patients undergoing cardiac surgery. Semin Thorac Cardiovasc Surg 1999, 11:84-104.
24. Levy M.M., Fink M.P., Marshall J.C., et al. SCCM/ESICM/ACCP/ATS/SIS - 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256.
25. Riley E., Cohen S., Rubenstein, Flanagan B. Prevention of hypotension after spinal anesthesia for cesarean section: six percent hetastarch versus lactated Ringer's solution. Anesth Analg 1995, 81:838-842.
26. Hartog C.S., Bauer M., Reinhart K. The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg 2011, 112:156-164.
27. Langdown A.J., Field J., Grote J., Himayat H. Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty. J Arthroplasty 2000, 15:1009-1012.
28. Ellger B., Freyhoff J., van Aken H., Marcus M.A.E., Booke M. High dose volume replacement using HES 130/0.4 during major surgery does not alter coagulation. Europ J of Anaesth 2002, 19:297.
29. Rosencher N., Kerkkamp H.E., Macheras G., et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003, 43:459-469.
30. Holcomb J.B. Methods for improved hemorrhage control. Crit Care 2004, 8:S57-S60.
31. Fraga A., de O., Fantoni D.T., Otsuki D.A., Pasqualucci C.A., Abduch M.C., Auler J.O.C. Evidence for myocardial defects under extreme acute normovolemic hemodilution with hydroxyethyl starch and lactated Ringer's solution. Shock 2005, 24:388-395.
32. Margarido C.B., Margarido N.F., Otsuki D.A., et al. Pulmonary function is better preserved in pigs when acute normovolemic hemodilution is achieved with hydroxyethyl starch versus lactated Ringer's solution. Shock 2007, 27:390-396.
33. Otsuki D.A., Fantoni D.T., Margarido C.B., et al. Hydroxyethyl starch is superior to lactated Ringer as a replacement fluid in a pig model of acute normovolaemic haemodilution. Br J Anaesth 2007, 98:29-37.
34. Ruttmann T.G., James M.F., Finlayson J. Effects on coagulation of intravenous crystalloid or colloid in patients undergoing peripheral vascular surgery. Br J Anaesth 2002, 89:226-230.
35. Kozek-Langenecker S. In vitro testing of haemostatic sideeffects of colloids. Acta Anaesthesiol Scand 2006, 50:518.
36. Thyes C., Madjdpour C., Frascarolo P., et al. Effect of high- and low-molecular-weight low-substituted hydroxyethyl starch on blood coagulation during acute normovolemic hemodilution in pigs. Anesthesiol 2006, 105:1228-1237.
37. Davies L., Brown T.J., Haynes S., Payne K., Elliott R.A., McCollum C. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess 2006, 10(iii-iv):ix-x. 1-210.
38. Jones S.B., Whitten C.W., Despotis G.J., Monk T.G. The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers. Anesth Analg 2003, 96:363-368.
39. Lang K., Boldt J., Suttner S., Haisch G. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg 2001, 93:405-409.
40. Boldt J., Lehmann A., Römpert R., Haisch G., Isgro F. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2000, 14:264-268.
41. Karanko M.S., Klossner J.A., Laaksonen V.O. Restoring volume by crystalloid versus colloid after coronary artery bypass: hemodynamics, lung water, oxygenation, and outcome. Crit Care Med 1987, 15:559-566.
42. Boldt J., Knothe C., Zickmann B., et al. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg 1993, 76:1185-1190.
43. Haisch G., Boldt J., Krebs C., et al. Influence of a new hydroxyethyl starch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth 2001, 15:316-321.
44. Gallandat R.C.G., Siemons A.W., Baus D., et al. A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anesth 2000, 47:1207-1215.
45. Grauer M.T., Baus D., Woessner R., et al. Effects on general safety and coagulation after long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study. Critical Care 2001, 5:P115-S154.
46. Langeron O., Doelberg M., Ang E.T., Bonnet F., Capdevila X., Coriat P. Voluven® a lower substituted novel hydroxyethylstarch (HES 130/0.4) causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001, 92:855-862.
47. Gandhi S.D., Weiskopf R.B., Jungheinrich C., et al. Volume replacement therapy during major orthopedic surgery using Voluven® (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiol 2007, 106:1120-1127.
48. Hébert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340:409-417.
49. Taylor R.W., O'Brien J.R.N., Trottier Steven J., et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Crit Care Med 2006, 34:2302-2308.
50. Hladik W., Dollard Sheila, Mermin J., et al. Transmission of Human Herpesvirus 8 by Blood Transfusion. New Engl J Med 2006, 355:1331-1338.
51. Innerhofer P., Walleczek C., Luz G., et al. Transfusion of buffy coatdepleted blood components and risk of postoperative infection in orthopedic patients. Transfusion 1999, 39:625-632.
52. Spiess B.D. Red cell transfusions and Guidelines: a work in progress. Hematol Oncol Clin North Am 2007, 21:185-200.
53. D'Ambrosio A., Borghi B., Damato A., D'Amato G., Antonacci D., Valeri F. Reducing perioperative blood loss in patients undergoing total hip arthroplasty. Int J Artif Organs 1999, 22:47-51.
54. Lentschener C., Cottin P., Bouaziz H., et al. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion. Anesth Analg 1999, 89:590-597.
55. Finfer S., Bellomo R., Boyce N., French J., Myburgh J., Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2256.
56. Cardinal D.C., Flower R.J. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980, 3:135-158.
57. Bernard G.R., Artigas A., Brigham K.L., et al. The American- European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. AmJ Respir Crit Care Med 1994, 149:818-824.
58. Thygesen K., Alpert J.S., White H.D. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction - Universal definition of myocardial infarction. J Am Coll Cardiol 2007, 50:2173-2195.
59. Haase M., Bellomo R., Matalanis G., Calzavacca P., Dragun D., Haase- Fielitz A. A comparison of the RIFLE and Acute Kidney Injury Network classifications for cardiac surgery - associated acute kidney injury. J Thorac Cardiovasc Surg 2009, 138:1370-1376.
60. Despotis G.J., Skubas N.J., Goodnough L.T. Optimal management of bleeding and transfusion in patients undergoing cardiac surgery. Semin Thorac Cardiovasc Surg 1999, 11:84-104.
61. Levy M.M., Fink M.P., Marshall J.C., et al. SCCM/ESICM/ACCP/ATS/SIS - 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256.
62. Riley E., Cohen S., Rubenstein, Flanagan B. Prevention of hypotension after spinal anesthesia for cesarean section: six percent hetastarch versus lactated Ringer's solution. Anesth Analg 1995, 81:838-842.
63. Hartog C.S., Bauer M., Reinhart K. The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg 2011, 112:156-164.
64. Langdown A.J., Field J., Grote J., Himayat H. Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty. J Arthroplasty 2000, 15:1009-1012.
65. Ellger B., Freyhoff J., van Aken H., Marcus M.A.E., Booke M. High dose volume replacement using HES 130/0.4 during major surgery does not alter coagulation. Europ J of Anaesth 2002, 19:297.
66. Rosencher N., Kerkkamp H.E., Macheras G., et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003, 43:459-469.
67. Holcomb J.B. Methods for improved hemorrhage control. Crit Care 2004, 8:S57-S60.
68. Fraga A., de O., Fantoni D.T., Otsuki D.A., Pasqualucci C.A., Abduch M.C., Auler J.O.C. Evidence for myocardial defects under extreme acute normovolemic hemodilution with hydroxyethyl starch and lactated Ringer's solution. Shock 2005, 24:388-395.
69. Margarido C.B., Margarido N.F., Otsuki D.A., et al. Pulmonary function is better preserved in pigs when acute normovolemic hemodilution is achieved with hydroxyethyl starch versus lactated Ringer's solution. Shock 2007, 27:390-396.
70. Otsuki D.A., Fantoni D.T., Margarido C.B., et al. Hydroxyethyl starch is superior to lactated Ringer as a replacement fluid in a pig model of acute normovolaemic haemodilution. Br J Anaesth 2007, 98:29-37.
71. Ruttmann T.G., James M.F., Finlayson J. Effects on coagulation of intravenous crystalloid or colloid in patients undergoing peripheral vascular surgery. Br J Anaesth 2002, 89:226-230.
72. Kozek-Langenecker S. In vitro testing of haemostatic sideeffects of colloids. Acta Anaesthesiol Scand 2006, 50:518.
73. Thyes C., Madjdpour C., Frascarolo P., et al. Effect of high- and low-molecular-weight low-substituted hydroxyethyl starch on blood coagulation during acute normovolemic hemodilution in pigs. Anesthesiol 2006, 105:1228-1237.
74. Davies L., Brown T.J., Haynes S., Payne K., Elliott R.A., McCollum C. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess 2006, 10:1-210. iii-iv, ix-x.